Ampersand acquires majority stake in in vitro diagnostics company ALPCO
Ampersand Capital Partners, a middle-market private equity firm, has acquired a majority stake in American Laboratory Products Company (ALPCO), an in vitro diagnostics company, for an undisclosed price. Established in 1990, ALPCO started off as an importer and distributor of immunoassay-based products serving the North American life science markets. Currently, the company offers its proprietary […]